Nano-vehicles modulated delivery of therapeutic epigenetic regulators to treat Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Nano-vehicles modulated delivery of therapeutic epigenetic regulators to treat Triple-Negative Breast Cancer

Published:2022-11 Issue: Volume:77 Page:103924
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Flores-Contreras Elda A.^ORCID,González-González Reyna Berenice^ORCID,González-González Everardo,Parra-Saldívar Roberto^ORCID,Iqbal Hafiz M.N.^ORCID

Funder

Sistema Nacional de Investigadores

Consejo Nacional de Ciencia y Tecnología

Instituto Tecnológico y de Estudios Superiores de Monterrey

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference147 articles.

1. Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer;Yang,2021

2. Quality of Life (QoL) of cancer patients and its association with nutritional and performance status: a pilot study;Alam;Heliyon,2020

3. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer;Chadar;Int. J. Pharm.,2021

4. Epigenetic alterations in triple-negative breast cancer—the critical role of extracellular matrix;Zolota;Cancers,2021

5. Nanomaterials for cancer therapies;Zhou;Nanotechnol. Rev.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision-engineered PEGylated liposome for dual payload delivery: enhancing efficacy of Doxorubicin hydrochloride and miR-145 mimics in breast cancer cells;Journal of Liposome Research;2024-08-05

2. Therapeutic regulation of epigenetics in cancer treatment through drug delivery systems;Nano Today;2024-06

3. Applying thermodynamics as an applicable approach to cancer diagnosis, evaluation, and therapy: A review;Journal of Drug Delivery Science and Technology;2023-09

4. Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging;Chemical & Biomedical Imaging;2023-03-21